![Bruce Beutel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce Beutel
Plus aucun poste en cours
Profil
Bruce A. Beutel is the founder of Passkey Therapeutics, Inc. Dr. Beutel is currently a Director at GRO Biosciences, Inc. since 2021 and a Director at Boston Immune Technologies & Therapeutics, Inc. Formerly, Dr. Beutel was Senior Director-Target & Lead Discovery at Abbott Laboratories from 1995 to 2007, Executive Director at Merck & Co., Inc., Group Head-Discovery & Senior Scientist at PharmaGenics, Inc. from 1993 to 1995, Chief Scientific Officer at Znomics, Inc. from 2008 to 2009, and Venture Partner at Qiming US Ventures Management, LLC from 2021 to 2022.
Dr. Beutel completed undergraduate studies at The University of Chicago and earned a doctorate from the University of Wisconsin.
Postes actifs de Bruce Beutel
| Sociétés | Poste | Début |
|---|---|---|
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops protein-based therapies | Directeur/Membre du Conseil | 09/12/2021 |
Boston Immune Technologies & Therapeutics, Inc.
 Boston Immune Technologies & Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapy | Directeur/Membre du Conseil | - |
Enveda Therapeutics, Inc.
 Enveda Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery platform | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de Bruce Beutel
| Sociétés | Poste | Fin |
|---|---|---|
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Analyste en capital-investissement | 01/12/2022 |
Znomics, Inc.
 Znomics, Inc. Financial ConglomeratesFinance Operates as a shell company | Directeur Technique/Scientifique/R&D | 03/06/2009 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2007 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for cancer | Directeur Technique/Scientifique/R&D | 01/01/1995 |
| MERCK & CO., INC. | Directeur/Membre du Conseil | - |
Formation de Bruce Beutel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for cancer | Commercial Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Znomics, Inc.
Znomics, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops protein-based therapies | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Boston Immune Technologies & Therapeutics, Inc.
Boston Immune Technologies & Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapy | Health Technology |
Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery platform | Technology Services |
